Search Results
Nov 12, 2025, 07:47 ET EirGenix Signed The Commercial Licensing Agreement for Its Second HER2 Biosimilar Asset EG1206A
the European Medicines Agency (EMA), confirming that the product qualifies for an abbreviated development pathway, allowing for the waiver of Phase III comparative efficacy trials. This agreement marks another major milestone and breakthrough in EirGenix's biosimilar development efforts. This partnership
More news about: EirGenix, Inc.
Nov 12, 2025, 07:44 ET Smart Sand, Inc. Announces Third Quarter 2025 Results
other results of operations based taxes; and (iii) interest expense. Adjusted EBITDA is defined as EBITDA, plus: (i) gain or loss on sale of fixed assets or discontinued operations; (ii) integration and transition costs associated with specified transactions; (iii) equity compensation; (iv) acquisition and
More news about: Smart Sand, Inc.
Nov 12, 2025, 07:17 ET Natural Grocers® Expands House Brand With 10 New Varieties of Organic Frozen Vegetables
www.naturalgrocers.com/npower. [iii] **Coming soon. RECENT
More news about: Natural Grocers by Vitamin Cottage, Inc.
Nov 12, 2025, 07:05 ET Pyxus International, Inc. Reports Solid Second Quarter Fiscal 2026 Results
in this table (in fiscal year 2016 the Company decided to exit green leaf sourcing in the Kenyan market as part of our restructuring program), and (iii) the subtraction of the Adjusted EBITDA of the industrial hemp operations, which is calculated on the same basis as Adjusted EBITDA presented in this
More news about: Pyxus International, Inc.
Nov 12, 2025, 06:59 ET Einride, a Leading Digital, Electric and Autonomous Freight Technology Company, to Go Public via a Business Combination with Legato Merger Corp. III at a $1.8 Billion Valuation
North America, Europe and the Middle East. About Legato Merger Corp. III: Legato Merger Corp. III (NYSEAMERICAN: LEGT) is a blank check company organized for the purpose of effecting a merger, capital stock exchange,
More news about: Einride
Nov 12, 2025, 06:55 ET Einride, a Leading Digital, Electric and Autonomous Freight Technology Company, to Go Public via a Business Combination with Legato Merger Corp. III at a $1.8 Billion Valuation
North America, Europe and the Middle East. About Legato Merger Corp. III: Legato Merger Corp. III (NYSEAMERICAN: LEGT) is a blank check company organized for the purpose of effecting a merger, capital stock exchange,
More news about: Einride
Nov 12, 2025, 06:00 ET Hyperscale Data Deploying 4,092 New Generation Bitmain Bitcoin Miners, Accelerating Bitcoin Production and Advancing Company Goal of $100 Million Bitcoin Treasury Strategy
Data at the forefront of two major technological movements. "We are very pleased with our execution," said Milton "Todd" Ault III, Executive Chairman of Hyperscale Data. "We are buying Bitcoin on top of our mining operations, allowing us to accumulate Bitcoin
More news about: Hyperscale Data Inc.
Nov 12, 2025, 05:02 ET 제8회 중국 국제 서커스 페스티벌, 헝친에서 일주일간 세계 정상급 공연 선보여
지금도 끊임없이 진화하는 가운데 전통에 충실하면서도 혁신을 잊지 않기 위해 수고를 아끼지 않고 있다. 세계 최고 서커스만을 엄선해 보여줬던 초창기 국제 서커스 갈라(International Circus Gala)부터 세계 최대 규모 실황 서커스 매직 레전드(Magic Legend)와 업그레이드 버전 매직 레전드 III, 여기에 제31회 TEA 테아 어워드 스펙터클(TEA Thea Award for Outstanding Achievement) 쇼 부문 우수상 수상작인 키멜롱 쇼까지 키멜롱은 양질의 문화 콘텐츠와 엔터테인먼트 프로그램에 대한 오랜 노하우를 보여주는 공연을 연중 꾸준히 선보이고 있다.
More news about: Chimelong Group
Nov 12, 2025, 04:03 ET TORM plc capital increase in connection with delivery of one LR2 vessel and exercise of Restricted Share Units as part of TORM's incentive program
any special rights and are negotiable instruments, (ii) give right to dividends and other rights in relation to TORM as of the date of issuance and (iii) are expected to be admitted to trading and official listing on Nasdaq Copenhagen as soon as possible. After the capital increase,
More news about: Torm PLC
Nov 12, 2025, 03:30 ET HUYA Inc. Reports Third Quarter 2025 Unaudited Financial Results
and exclusion of the impact of (i) share-based compensation expenses, (ii) gain arising from disposal of an equity investment, net of income taxes, (iii) impairment loss of investments, and (iv) amortization of intangible assets from business acquisitions (net of income taxes), add clarity to the constituent
More news about: HUYA Inc.
Nov 12, 2025, 02:48 ET BPC Instruments reports results for the period January - September 2025
July, BPC received an order from Cornell University in the United States valued at approximately SEK 1 million. The order includes two AMPTS® III Duo systems – BPC's flagship instrument for conducting batch anaerobic fermentation tests. On 5 August, BPC received an order
More news about: BPC Instruments AB
Nov 12, 2025, 02:02 ET Shilpa Medicare 宣佈 OERIS™ 第 3 期臨床試驗正面成果 -- 這是新型兼每週注射的昂丹司瓊緩釋注射劑，舒緩化療引起的噁心與嘔吐 (CINV)
在差異化藥物遞送系統與腫瘤科支持治療中的日益成長領導地位，也反映該公司致力推進病人為中心的創新。 研究概述 一項多中心、隨機、雙盲兼非劣效性 III 期試驗，在印度多個腫瘤中心進行。在 240 名接受中度或高度致吐性化療的病人中，比較 OERIS™ 與傳統昂丹司瓊注射劑的療效。 設計與端點
More news about: Shilpa Medicare Limited
Nov 11, 2025, 23:41 ET Shilpa Medicare gibt positive Phase-III-Ergebnisse für OERIS™ bekannt - eine neuartige, einmal wöchentlich verabreichte Ondansetron-Injektion mit verlängerter Wirkstofffreisetzung zur Behandlung von Übelkeit und Erbrechen, ausgelöst durch Chemotherapie (CINV)
In der Phase-III-Studie wurden alle primären und sekundären Endpunkte erreicht, was im Vergleich zu herkömmlichen Ondansetron-Injektionen eine überlegene Benutzerfreundlichkeit, starke Wirksamkeit sowie ausgezeichnete Sicherheit belegt
More news about: Shilpa Medicare Limited
Nov 11, 2025, 23:36 ET The 8th China International Circus Festival Celebrates a Week of World-Class Performances at Hengqin Chimelong
Gala, a showcase of the world's finest circus acts, to Magic Legend, the world's first large-scale situational circus, and its enhanced Magic Legend III, as well as the Chimelong Show, winner of the 31st TEA Thea Award for Outstanding Achievement in the Spectacle Show category, Chimelong continues to
More news about: Chimelong Group
Nov 11, 2025, 23:24 ET The 8th China International Circus Festival Celebrates a Week of World-Class Performances at Hengqin Chimelong
Gala, a showcase of the world's finest circus acts, to Magic Legend, the world's first large-scale situational circus, and its enhanced Magic Legend III, as well as the Chimelong Show, winner of the 31st TEA Thea Award for Outstanding Achievement in the Spectacle Show category, Chimelong continues to
More news about: Chimelong Group
Nov 11, 2025, 17:31 ET Antibody-Mediated Rejection Market Set to Expand Significantly During the Forecast Period (2025-2034) Amid Advances in Diagnostics and Targeted Therapies | DelveInsight
transplant recipients has been completed. According to the company's pipeline, results from the U.S. Phase III ConfIdeS trial (NCT04935177) are expected in the second half of 2025, while the European Phase III readout for kidney transplant desensitization is anticipated in 2026.
More news about: DelveInsight Business Research, LLP
Nov 11, 2025, 17:30 ET Adecoagro S.A.:Adjusted EBITDA reached $115.1 million in 3Q25. All-time crushing record and switch to ethanol maximization. Challenging global price scenario continues.
this press release relate to, among others: (i) our business prospects and future results of operations; (ii) weather and other natural phenomena; (iii) developments in, or changes to, the laws, regulations and governmental policies governing our business, including limitations on ownership of farmland
More news about: Adecoagro S.A.
Nov 11, 2025, 16:50 ET DXCM Stockholders With Large Losses Should Contact Robbins LLP for Information About Leading the Dexcom, Inc. Securities Fraud Class Action
and G7 less reliable than their prior iterations, presenting a material health risk to users relying on those devices for accurate glucose readings; (iii) accordingly, defendants' purported enhancements to the G7, as well as the device's reliability, accuracy, and functionality, were overstated; (iv) defendants
More news about: Robbins LLP
Nov 11, 2025, 16:05 ET Shoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance
replaced in the future, and Adjusted EBITDA does not reflect cash capital expenditures for such replacements or for new capital expenditure requirements; (iii) Adjusted EBITDA also does not reflect changes in, or cash requirements for, our working capital needs or the potentially dilutive impact of stock-based
More news about: Shoulder Innovations
Nov 11, 2025, 16:05 ET QuickLogic Reports Fiscal Third Quarter 2025 Financial Results
charges related to stock-based compensation and restructuring costs, in calculating non-GAAP (i) income (loss) from operations, (ii) net income (loss), (iii) net income (loss) per share, and (iv) gross margin percentage. The Company provides this non-GAAP information to enable investors to evaluate its operating
More news about: QuickLogic Corporation
Nov 11, 2025, 16:05 ET LightPath Technologies Reports Fiscal 2026 First Quarter Financial Results
growth; (ii) our ability to execute on our growth strategy, including with respect to our ability to move towards fully integrated IR camera systems; (iii) expectations regarding growing supply chain risks and Chinese export restrictions on critical minerals; (iv) customer demand of our products; and (vi)
More news about: LightPath Technologies
Nov 11, 2025, 13:53 ET Lundbeck delivers 14% CER revenue growth, reflecting stronger momentum from Vyepti® and Rexulti® driven by additional investments
Disease and Movement Disorders® in Honolulu, Hawaii (5-9 October). At the congress, Lundbeck shared Insights into the design of the phase III MASCOT trial and its use of innovative Bayesian progression modeling methods. On 20 September 2025, Lundbeck and Otsuka
More news about: H. Lundbeck A/S
Nov 11, 2025, 13:38 ET Lundbeck delivers 14% CER revenue growth, reflecting stronger momentum from Vyepti® and Rexulti® driven by additional investments
Disease and Movement Disorders® in Honolulu, Hawaii (5-9 October). At the congress, Lundbeck shared Insights into the design of the phase III MASCOT trial and its use of innovative Bayesian progression modeling methods. On 20 September 2025, Lundbeck and Otsuka
More news about: H. Lundbeck A/S
Nov 11, 2025, 11:30 ET Medical Device Outsourcing Market to hit $386.08 Billion by 2033 - Grand View Research, Inc.
II Class III Diagnostic imaging Class I Class II Class III
More news about: Grand View Research, Inc.
Nov 11, 2025, 10:51 ET Falcon Gold Targets Expansion of High-Grade Gold System with New Exploration Permit Application at Central Canada Project, Ontario
regional gold-bearing structure. Phase III Drilling to Build on High-Grade Results The newly submitted permit supports Falcon's Phase III drilling, targeting 1.6 kilometres of strike length along the historic Central
More news about: Falcon Gold Corp.